Dual-Energy CT Vital Iodine Tumor Burden for Response Assessment in Patients With Metastatic GIST Undergoing TKI Therapy: Comparison With Standard CT and FDG PET/CT Criteria
Mathias Meyer, Peter Hohenberger, Daniel Overhoff, Anna Bartsch, Thomas Henzler, Holger Haubenreisser, James Ronald, Bernhard Schmidt, Thomas Flohr, Martin Sedlmair, Hideki Ota, Christina Messiou, Stefan O. Schoenberg, Richard F. Riedel, Rendon C. Nelson, Daniele Marin
Abstract
DECT vital iodine TB could help guide early management decisions in patients receiving TKI therapy.
Topics & Concepts
MedicineResponse Evaluation Criteria in Solid TumorsGiSTConcordanceRadiologyHazard ratioIodineNuclear medicineProportional hazards modelCancerRetrospective cohort studySunitinibClinical trialInternal medicineSorafenibStromal tumorConfidence intervalAdvanced X-ray and CT ImagingAdvanced X-ray Imaging TechniquesGastrointestinal Tumor Research and Treatment